DENTSPLY SIRONA Profit Margin 2010-2023 | XRAY

Current and historical gross margin, operating margin and net profit margin for DENTSPLY SIRONA (XRAY) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. DENTSPLY SIRONA net profit margin as of December 31, 2023 is -3.33%.
DENTSPLY SIRONA Annual Profit Margins
DENTSPLY SIRONA Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $6.296B $3.965B
DENTSPLY SIRONA Inc. is a global leader in the design, development, manufacture and marketing of dental consumables, dental laboratory products, dental specialty products and consumable medical device products. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. The business has been organized into two reporting segments: Dental & Healthcare Consumables and Technologies.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $69.110B 18.50
Becton Dickinson (BDX) United States $67.086B 19.48
West Pharmaceutical Services (WST) United States $27.625B 46.70
Cardinal Health (CAH) United States $25.909B 15.57
Align Technology (ALGN) United States $22.586B 45.54
Cooper (COO) United States $17.860B 27.03
Labcorp (LH) United States $16.823B 14.37
Henry Schein (HSIC) United States $9.019B 15.60
Merit Medical Systems (MMSI) United States $4.152B 23.76
Patterson (PDCO) United States $2.305B 11.04
STAAR Surgical (STAA) United States $2.264B 71.29
CONMED (CNMD) United States $2.240B 21.09
Atrion (ATRI) United States $0.702B 36.15
Lifevantage (LFVN) United States $0.085B 13.75
Pro-Dex (PDEX) United States $0.064B 24.35
Biolase (BIOL) United States $0.005B 0.00